Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

New Breathalyzer Detects When Your Body Is Burning Fat

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

Over-the-Counter Continuous Glucose Monitors: Okay for Kids?

A pediatric endocrinologist raises questions about use in youth without diabetes.

One Ultrasound Scan Flags Both MASH and Liver Scarring

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

Surprising Signal for Semaglutide in Bipolar Disorder

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT Surpasses MRI in Vertebral Bone Quality Assessment

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

Traditional Chinese Medicines Plus Metformin Improve A1c

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Latest News

A hand-held device that measures acetone levels in your breath — signaling ketosis — matched mass spectrometry tests for accuracy. But clinical uses may be limited for now.

A pediatric endocrinologist raises questions about use in youth without diabetes.

A novel ultrasound-derived score combined with liver stiffness measurement can identify both MASH and fibrosis, potentially reducing the need for biopsy.

The GLP-1 semaglutide was linked to fewer psychiatric hospitalizations in patients with bipolar disorder, raising the possibility of benefits beyond weight loss and glycemic control.

Lumbar CT attenuation measurements outperform MRI-derived vertebral bone quality scores for diagnosing osteopenia and osteoporosis in degenerative spinal populations.

In a phase 3 trial, adding a combo of two traditional Chinese meds to metformin reduced A1c and improved lipid measure in patients with T2D whose glycemic control was inadequate with metformin alone.

News All Time

FDA OKs Gene Therapy for Glycogen Storage Disease Type Ia

The FDA grants accelerated approval for the innovative, one-time gene therapy Genglycos to treat the rare disease GSDIa in children aged 8 years and older and adults.

Does Telehealth-Only GLP-1 Care Fall Short?

Many vital tests and evaluations a patient needs before and after starting GLP-1s can’t be done over the computer.

Partner Weight Loss Increases When Included in Program

A behavioral weight-loss program aimed at one partner can produce meaningful, lasting weight loss in the other — despite never asking them to change their own habits.

Fatigue, Brain Fog Persist in Women With Prolactinoma

Even with prolactin levels under control, many women with a prolactinoma still battle fatigue and concentration problems, a new Dutch cohort study reveals.

Is There a ‘Best’ GLP-1 Injection Site?

Experts say any of the three approved subcutaneous injection sites for GLP-1s will work, but users, and some social media influencers, have strong opinions about which is best.

More US Employers to Drop Weight-loss Drugs in 2027, as Healthcare Costs Increase

About 14% of employers in the United States have already or plan to drop GLP-1 drugs in 2027, as companies see ⁠rising healthcare costs, according to a survey released on...

Trump's Weight; Fauci Gets a Legal Defense Fund; Eye Drops Recalled

— Health news and commentary gathered by MedPage Today staff

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Recognizing Patients With High Risk T1D: Clinical Indicators of IAH and Recurrent Severe Hypoglycemia

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Foundations and Frontiers in Acromegaly: Pathophysiology, Current Treatments, and Emerging SRLs

Judge Questions Hegseth's Testosterone Policy Amid Military's Transgender Care Ban

Parties ordered to address "similarities and differences in administering TRT" to both groups

FDA Panel Endorses Lifting Restrictions on Peptides Backed by RFK Jr.

Votes go against agency scientists' recommendation to keep them off the compounding list

1,300 Dead in Outbreak; Cyclospora Response 'Mismanaged'? GLP-1 Access in Medicaid

Health news and commentary gathered by MedPage Today staff

Even Short Bouts of Antipsychotics Linked to Diabetes Risk

Risks rose through year 5 in youths, but were seen after even just 1 year

Surgery Underused for Primary Hyperparathyroidism With End-Organ Damage, Study Says

Large study highlights gap between guidelines and clinical practice

Thyroid Meds Recalled Nationwide; Worst GLP-1 for Hair Loss? PMOS Prevalence

News and commentary from the endocrinology world

Florida Investigates Fauci; Obesity Drug Trial Sparks Lawsuit; 'Early Bird' Dinners

Health news and commentary gathered by MedPage Today staff

Recommended News For You

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

New study elucidates obesity's role in fueling breast cancer progression

Bladder cancer link to explosive ordnance exposure among Army veteran bomb disposal officers

Eight Doctors Killed in Brazil's Horrifying Plane Crash

Ultrasonography of hepatocellular carcinoma: From diagnosis to prognosis

Discovery reveals protein involved in Parkinson's disease also drives skin cancer

Body Clock Genes Tied to Prostate Radiotherapy Toxicity

Recommended Articles For You

Risk Assessment of Bone-Marrow Reserve Under Repeated Physiological Demands 

Getting to Know RDW and SD: How They Relate to Anemia, Inflammation, and More  

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources 

Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

2.

Black Canadians Face Multiple Barriers to Blood Donation

3.

Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening

4.

Experts say oncology, primary care coordination necessary for best cancer patient outcomes

5.

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors

1.

Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice

2.

Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations

3.

Clinical Frameworks in Hematology for Better Care

4.

Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence

5.

The Benefits of Understanding Haptoglobin High: What You Need to Know

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

3.

Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

5.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot